These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12082026)

  • 21. Braf Mutations Initiate the Development of Rat Gliomas Induced by Postnatal Exposure to N-Ethyl-N-Nitrosourea.
    Wang Q; Satomi K; Oh JE; Hutter B; Brors B; Diessl N; Liu HK; Wolf S; Wiestler O; Kleihues P; Koelsch B; Kindler-Röhrborn A; Ohgaki H
    Am J Pathol; 2016 Oct; 186(10):2569-76. PubMed ID: 27658714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. neu mutation in schwannomas induced transplacentally in Syrian golden hamsters by N-nitrosoethylurea: high incidence but low allelic representation.
    Buzard GS; Enomoto T; Hongyo T; Perantoni AO; Diwan BA; Devor DE; Reed CD; Dove LF; Rice JM
    J Cancer Res Clin Oncol; 1999 Oct; 125(10):529-40. PubMed ID: 10473865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat model of the human "Triton" tumor: direct genetic evidence for the myogenic differentiation capacity of schwannoma cells using the mutant neu gene as a cell lineage marker.
    Nikitin AYu ; Lennartz K; Pozharisski KM; Rajewsky MF
    Differentiation; 1991 Sep; 48(1):33-42. PubMed ID: 1683842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic dissection of the Mss4 locus mediating sex-biased cancer resistance in the rat peripheral nervous system.
    van den Berg L; Koelsch BU; Winzen-Reichert B; Fischer C; Kutritz A; Kindler-Röhrborn A
    Int J Cancer; 2015 May; 136(9):2099-108. PubMed ID: 25303613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea.
    Perantoni AO; Rice JM; Reed CD; Watatani M; Wenk ML
    Proc Natl Acad Sci U S A; 1987 Sep; 84(17):6317-21. PubMed ID: 3476947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of susceptibility of rats to trigeminal schwannomas induced by neonatal administration of N-ethyl-N-nitrosourea.
    Naito M; Ito A; Aoyama H
    J Natl Cancer Inst; 1985 Jan; 74(1):241-5. PubMed ID: 3855483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide loss of heterozygosity analysis of chemically induced rat hepatocellular carcinomas reveals elevated frequency of allelic imbalances on chromosomes 1, 6, 8, 11, 15, 17, and 20.
    Teeguarden JG; Newton MA; Dragan YP; Pitot HC
    Mol Carcinog; 2000 May; 28(1):51-61. PubMed ID: 10820488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice.
    Cool M; Jolicoeur P
    Cancer Res; 1999 May; 59(10):2438-44. PubMed ID: 10344755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of the Loss of Heterozygosity of the
    DE Carvalho RM; DE Castro Sant' Anna C; Pinto GR; Paschoal EHA; Tuji FM; DO Nascimento Borges B; Soares PC; Júnior AGF; Rey JA; Chaves LCL; Burbano RR
    Anticancer Res; 2018 Apr; 38(4):2149-2154. PubMed ID: 29599333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients.
    Pećina-Slaus N; Zeljko M; Pećina HI; Nikuseva Martić T; Bacić N; Tomas D; Hrasćan R
    Croat Med J; 2012 Aug; 53(4):321-7. PubMed ID: 22911524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
    Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
    Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang SM; Eklund LK; Cochran C; Rao GN; Wiseman RW; Söderkvist P
    Cancer Res; 1996 Jul; 56(14):3338-43. PubMed ID: 8764131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
    Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
    Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
    Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.